The conversation about collagen tends to begin when a patient first notices a change in their skin, which is usually in their 30s or 40s. By then, the biology that the conversation is actually about has been running quietly for a decade. Dermal collagen synthesis peaks in early adulthood and declines steadily through the rest of life, with the slope of that decline strongly influenced by ultraviolet exposure, smoking and other modifiable factors.
In the Australian climate, and in Queensland in particular, the gap between when the biology starts and when the patient notices is the most clinically important window in the entire ageing timeline. Treating it as a window for prevention rather than as a window for waiting changes the shape of what the next 30 years of skin look like.
The myth
Younger skin makes its own collagen. There is nothing to support, nothing to treat, and any intervention before visible ageing appears is unnecessary marketing.
The reality, briefly
Type I and type III collagen, produced by dermal fibroblasts, provide most of the tensile strength of the skin. Population studies consistently show that dermal collagen content begins to decline from the mid-20s onward, with reported losses on the order of around 1 per cent per year through adult life. Elastin, which gives skin recoil, regenerates poorly after damage. Hyaluronic-acid content within the dermis also declines with age, contributing to thinner, less hydrated skin.
Layered on top of intrinsic ageing is photoageing, driven primarily by UVA and UVB exposure. Photoageing is responsible for the majority of visible facial ageing in lighter skin types according to long-standing dermatology literature. In a high-UV environment, the photoageing curve and the intrinsic curve overlap and amplify each other from the late teens onward.
Why prevention is the work
Collagen and elastin lost in the 20s and 30s are not easily put back in the 50s. In-clinic treatments can stimulate new collagen synthesis, but they work with the biology that is still available, not with biology that has already been lost. The most reliably evidence-supported interventions for preserving long-term skin health are also the least glamorous.
- · Daily broad-spectrum sunscreen, SPF 30 or higher (50+ widely recommended in Australia), all year, including in winter and on overcast days. The Hughes et al. randomised trial published in Annals of Internal Medicine in 2013 demonstrated that regular sunscreen use significantly reduced visible skin ageing over four and a half years.
- · A topical retinoid at the tolerated frequency and concentration, under medical guidance. Retinoids have one of the strongest evidence bases in dermatology for stimulating dermal collagen and improving photoaged skin.
- · A topical antioxidant such as vitamin C, used in the morning under sunscreen, to support the cellular environment in which collagen synthesis occurs.
- · Not smoking. Smoking accelerates collagen loss, impairs cutaneous microcirculation, and is associated with deeper perioral lines and earlier skin ageing.
- · Adequate sleep, a varied diet with sufficient protein and antioxidants, and management of chronic stress, all of which influence the substrate available for dermal repair.
Where in-clinic care fits, before visible ageing
Periodic in-clinic care in younger skin is not about correction. It is about maintaining the biology you still have. Categories that may be considered, always after a medical consultation, include bio-remodelling treatments that aim to support dermal hydration and quality, medical skin needling protocols that aim to stimulate fibroblast activity, and clinically prescribed cosmeceutical skincare to address pigment, texture or barrier function before they become entrenched concerns. The cadence is conservative: a small number of thoughtfully spaced sessions per year, sequenced around season and skin tolerance, rather than a busy calendar of one-off treatments.
In Queensland, the prevention conversation is the treatment conversation, just earlier.
Why this is not a sales argument
Recommending prevention in younger skin sometimes draws scepticism, often because the marketing landscape has primed patients to expect upsell. The clinical position is the opposite. Most younger patients require less in-clinic care, not more, but the small amount of in-clinic care they do receive should be aligned with the biology that is actively running underneath the skin. The aim is to keep the next 30 years of skin healthier than they would otherwise be, not to start a long lifecycle of cosmetic dependence.
An honest consultation with a younger patient will sometimes conclude that the priority is daily sunscreen, a retinoid, and a medical skin check, and that an in-clinic procedure is not currently indicated. That is the same recommendation a thoughtful practitioner would have made twenty years ago, and it is, alongside not smoking, the single most important contribution to long-term skin health that medicine has to offer.
What to take from this
Younger skin does need collagen support, in the broad sense of the term. The support that matters most is environmental: UV protection, behavioural factors, and a daily routine with strong evidence behind it. In-clinic care, when indicated, complements that foundation. It does not replace it.
All cosmetic procedures carry risks. Outcomes vary between individuals. A consultation with a registered medical practitioner is required prior to any treatment. This article is general information only and is not medical advice.